OKEx Announces Listing Of TRX On The C2C Platform To Trade In Various Currencies
OkEx, the cryptocurrency exchange based in Malta, has added a new Tron (TRX) to their...
Read More
Cymabay Therapeutics Inc. (NASDAQ:CBAY) Provide Corporate Updates Indicating Initiation Of ENHANCE Study Of Seladelpar l In Q42018
CymaBay Therapeutics Inc. (NASDAQ:CBAY) gained 5% in the last trading session to close at $13.22...
Read More
PTC Therapeutics Inc. (NASDAQ:PTC) Report Revenue Of $86.3 In Q4 Driven By Sales Of Emflaza And Translarna
PTC Therapeutics Inc. (NASDAQ:PTC) lost 1.3% in the last trading sessions to close at $33.42 at...
Read More
Coheres Biosciences Inc. (NASDAQ:CHRS) Report Completion Of UDENYCA Which Helped Offset Expenses In Q42018
Coheres Biosciences Inc. (NASDAQ:CHRS) gained 1.49% in the previous trading session to close at...
Read More
Cerus Corporation (NASDAQ:CERS) Announces Fourth Quarter and Full Year 2018 Financial Results
Cerus Corporation (NASDAQ:CERS) closed Thursday’s trading session at $6.48, almost two weeks...
Read More
Radius Health Inc (NASDAQ:RDUS) Reports Its 2018 Fourth Quarter and Full Year Financial and Operating Figures
Radius Health Inc (NASDAQ:RDUS) closed Thursday’s trading session at $18.28, a week after it...
Read More
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Announces Its 2018 Fourth Quarter And Full Year Financials
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) closed Thursday’s trading session at $25.39 just...
Read More
Easton Pharmaceuticals Inc. (OTCMKTS:EAPH) Enters Agreement For Acquisition Of Commercial Bakery With $20 Million In Revenue
Easton Pharmaceuticals Inc. (OTCMKTS:EAPH) has announced that they have signed an agreement for...
Read More
Ionis Pharmaceuticals Inc (NASDAQ:IONS) Outperforms Its 2018 Financial Guidance
Ionis Pharmaceuticals Inc (NASDAQ:IONS) closed Thursday’s trading session at $69.81 as the...
Read More
Intellia Therapeutics Inc (NASDAQ:NTLA) Exonerates CEO From Participation As A Nominee In Briston-Myers Board Debate
Intellia CEO, despite previously being included in Starboard’s five nominees chosen at the...
Read More
Sarepta Therapeutics Inc (NASDAQ:SRPT) To Run Its Route 79, The Duchenne Scholarship Program For The Second Year
Sarepta Therapeutics Inc (NASDAQ:SRPT) closed Wednesday’s trading session at $132.25, just...
Read More
Insys Therapeutics Inc (NASDAQ:INSY) Presents Epinephrine Nasal Spray Pharmacokinetic Study Data
Insys Therapeutics Inc (NASDAQ:INSY) closed Wednesday’s trading session at $5.95, and it has...
Read More
- 1
- ...
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- ...
- 106
Recent Articles
